首页> Haematologica> <i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.

<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Jonathan,Bond

第一单位： Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.;Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.;National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.

作者： Jonathan,Bond ^[1] ; Aurore,Touzart ^[2] ; Stéphane,Leprêtre ^[3] ; Carlos,Graux ^[4] ; Mario,Bargetzi ^[5] ; Ludovic,Lhermitte ^[2] ; Guillaume,Hypolite ^[2] ; Thibaut,Leguay ^[6] ; Yosr,Hicheri ^[7] ; Gaëlle,Guillerm ^[8] ; Karin,Bilger ^[9] ; Véronique,Lhéritier ^[10] ; Mathilde,Hunault ^[11] ; Françoise,Huguet ^[12] ; Yves,Chalandon ^[13] ; Norbert,Ifrah ^[11] ; Elizabeth,Macintyre ^[2] ; Hervé,Dombret ^[14] ; Vahid,Asnafi ^[2] ; Nicolas,Boissel ^[15]

作者单位： Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.;Systems Biology Ireland, School of Medicine, University College Dublin, Ireland.;National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland. ^[1] Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut National de Recherche Médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France. ^[2] INSERM U1245 and Department of Hematology, Centre Henri Becquerel and Normandie Université UNIROUEN, Rouen, France. ^[3] Department of Hematology, Université Catholique de Louvain (UCL), Centre Hospitalier Universitaire (CHU) Namur - Godinne site, Yvoir, Belgium. ^[4] University Medical Department, Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.;Swiss Group for Clinical Cancer Research (SAKK), Bern, Switerland. ^[5] Department of Hematology, CHU de Bordeaux, France. ^[6] Hematology Service, Hôpital St Eloi, Montpellier, France. ^[7] Hematology Service, CHU de Brest, Brest, France. ^[8] Hematology Service, CHU Hautepierre, Strasbourg, France. ^[9] Group for Research on Adult Acute Lymphoblastic Leukemia, Coordination Office, Centre Hospitalier Lyon Sud, Lyon, France. ^[10] PRES LUNAM, CHU Angers Service des Maladies du Sang and CRCINA INSERM, Angers, France. ^[11] Department of Hematology, CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. ^[12] University Medical Department, Division of Oncology, Hematology and Transfusion Medicine, Kantonsspital Aarau, Aarau, Switzerland.;Department of Oncology, Hematology Division, University Hospital, Geneva, Switzerland. ^[13] Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France. ^[14] Université Paris Diderot, Institut Universitaire d'Hématologie, EA-3518, AP-HP, University Hospital Saint-Louis, Paris, France nicolas.boissel@aphp.fr. ^[15]